ES Jaffe

6.4k total citations · 1 hit paper
57 papers, 5.0k citations indexed

About

ES Jaffe is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, ES Jaffe has authored 57 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 21 papers in Immunology and 18 papers in Oncology. Recurrent topics in ES Jaffe's work include Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Viral-associated cancers and disorders (13 papers). ES Jaffe is often cited by papers focused on Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Viral-associated cancers and disorders (13 papers). ES Jaffe collaborates with scholars based in United States, Netherlands and India. ES Jaffe's co-authors include Mark Raffeld, L. Jeffrey Medeiros, AF Gazdar, P. A. Bunn, GP Schechter, Yung‐Yi Chen, Darryl Shibata, Liu Xf, Fauci As and DL Longo and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and The American Journal of Surgical Pathology.

In The Last Decade

ES Jaffe

56 papers receiving 4.8k citations

Hit Papers

Mitogen requirements for the in vitro propagation of cuta... 1980 2026 1995 2010 1980 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas
    1980 387 citations AF Gazdar, P. A. Bunn et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
ES Jaffe United States 33 2.9k 2.4k 1.9k 1.1k 686 57 5.0k
Taizan Suchi Japan 32 2.5k 0.9× 1.6k 0.7× 1.5k 0.8× 708 0.6× 710 1.0× 143 4.1k
Naokuni Uike Japan 37 1.8k 0.6× 1.8k 0.7× 2.5k 1.3× 852 0.8× 518 0.8× 151 5.1k
Gorm Pallesen Denmark 36 4.5k 1.5× 4.5k 1.8× 1.8k 1.0× 802 0.7× 737 1.1× 103 7.4k
D Catovsky United Kingdom 38 1.9k 0.6× 862 0.4× 2.6k 1.4× 2.1k 1.9× 357 0.5× 106 5.1k
Marie‐Hélène Delfau‐Larue France 39 2.7k 0.9× 1.8k 0.7× 1.5k 0.8× 645 0.6× 1.1k 1.7× 118 4.3k
Morishige Takeshita Japan 31 1.6k 0.6× 1.1k 0.5× 1.0k 0.5× 407 0.4× 417 0.6× 172 3.2k
DM Knowles United States 28 3.0k 1.0× 4.3k 1.8× 864 0.5× 895 0.8× 142 0.2× 47 5.4k
Estella Matutes United Kingdom 60 6.8k 2.3× 3.0k 1.2× 4.4k 2.3× 7.3k 6.5× 593 0.9× 278 11.4k
Tadaaki Eimoto Japan 35 1.1k 0.4× 1.2k 0.5× 735 0.4× 259 0.2× 392 0.6× 120 4.3k
Jonathan W. Said United States 36 1.4k 0.5× 1.1k 0.4× 979 0.5× 475 0.4× 570 0.8× 70 3.5k

Countries citing papers authored by ES Jaffe

Since Specialization
Citations

This map shows the geographic impact of ES Jaffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ES Jaffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ES Jaffe more than expected).

Fields of papers citing papers by ES Jaffe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ES Jaffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ES Jaffe. The network helps show where ES Jaffe may publish in the future.

Co-authorship network of co-authors of ES Jaffe

This figure shows the co-authorship network connecting the top 25 collaborators of ES Jaffe. A scholar is included among the top collaborators of ES Jaffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with ES Jaffe. ES Jaffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dunleavy, Kieron, Nicole Grant, Stefania Pittaluga, et al.. (2009). Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab. Infectious Agents and Cancer. 4(S2). 3 indexed citations
2.
Pittaluga, Stefania, Theresa Davies‐Hill, Cornelius Miething, et al.. (2006). The transcription factor CCAAT/enhancer binding protein (C/EBP)beta is constitutively expressed in ALK-positive anaplastic large cell lymphomas (ALCL), and is dependent upon NPM-ALK kinase activity. mediaTUM (Technical University of Munich). 1 indexed citations
3.
Thiéblemont, Catherine, Svetlana Pack, Akira Sakai, et al.. (1999). Allelic loss of 11q13 as detected by MEN1-FISH is not associated with mutation of the MEN1 gene in lymphoid neoplasms. Leukemia. 13(1). 85–91. 6 indexed citations
4.
Jaffe, ES, et al.. (1996). 鼻および関連した結節外血管中心Tナチュラルキラー細胞リンパ腫に関するワークショップの報告-定義、鑑別診断及び疫学. The American Journal of Surgical Pathology. 20(1). 103–111. 3 indexed citations
5.
6.
7.
Raffeld, Mark, et al.. (1995). Differential diagnosis of CD3+, CD56+ T-cell leukemias [letter; comment]. Blood. 85(6). 1675–1676. 1 indexed citations
8.
Harris, NL, ES Jaffe, P. M. Banks, et al.. (1994). A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]. Blood. 84(5). 1361–1392. 125 indexed citations
9.
Bosch, Francesc, Pedro Jares, Elı́as Campo, et al.. (1994). PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood. 84(8). 2726–2732. 11 indexed citations
10.
11.
Mertz, Pamela, et al.. (1992). c-myc mRNA expression in minor salivary glands of patients with Sjögren's syndrome.. PubMed. 19(5). 693–9. 25 indexed citations
12.
Raffeld, Mark, et al.. (1991). Immunophenotypic analysis of acute lymphoblastic leukemia using routinely processed bone marrow specimens.. PubMed. 115(4). 338–42. 5 indexed citations
13.
Raffeld, Mark & ES Jaffe. (1991). bcl-1, t(11;14), and mantle cell-derived lymphomas [editorial]. Blood. 78(2). 259–263. 234 indexed citations
14.
15.
Whang‐Peng, J., Bunn Pa, Turid Knutsen, et al.. (1985). Cytogenetic Studies in Human T-cell Lymphoma Virus (HTLV)-Positive Leukemia-Lymphoma in the United States. JNCI Journal of the National Cancer Institute. 74(2). 357–69. 38 indexed citations
16.
17.
18.
Jaffe, ES, et al.. (1981). Induction of complement receptors in human cell lines derived from undifferentiated lymphomas.. PubMed. 45(3). 295–301. 1 indexed citations
19.
Gazdar, AF, et al.. (1980). Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood. 55(3). 409–417. 279 indexed citations
20.
Broder, S, et al.. (1978). Evolution of a lymphoma with helper T cell characteristics in Sezary syndrome. Blood. 52(3). 481–492. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taizan Suchi Breakdown of academic impact, for papers by Naokuni Uike Breakdown of academic impact, for papers by Gorm Pallesen Breakdown of academic impact, for papers by D Catovsky Breakdown of academic impact, for papers by Marie‐Hélène Delfau‐Larue Breakdown of academic impact, for papers by Morishige Takeshita Breakdown of academic impact, for papers by DM Knowles Breakdown of academic impact, for papers by Estella Matutes Breakdown of academic impact, for papers by Tadaaki Eimoto Breakdown of academic impact, for papers by Jonathan W. Said
Rankless by CCL
2026